Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Chaoju Eye Care HoldingsHKSE:02219 +0.20%93 PS Ratio is 1.14 as of Sep. 09, 2026, which is 35% below its 10-year median of 1.76. GuruFocus rates HKSE:02219 with a GF Score™ of 93/100 and a GF Value™ of HK$3.16 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 659 Healthcare Providers & Services companies, Chaoju Eye Care Holdings ranks better than 59.18% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Chaoju Eye Care Holdings's share price is HK$2.54.
Chaoju Eye Care Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 was HK$2.23. Hence, Chaoju Eye Care Holdings's PS Ratio for today is 1.14.
Good Sign:
Chaoju Eye Care Holdings Ltd stock PS Ratio (=1.18) is close to 10-year low of 1.08.
The historical rank and industry rank for Chaoju Eye Care Holdings's PS Ratio or its related term are showing as below:
HKSE:02219'
s PS Ratio Range Over the Past 10 Years
Min: 1.08 Med: 1.76 Max: 10.86
Current: 1.14
During the past 8 years, Chaoju Eye Care Holdings's highest PS Ratio was 10.86. The lowest was 1.08. And the median was 1.76.
HKSE:02219's PS Ratio is ranked better than 59.18% of 659
companies
in the Healthcare Providers & Services industry
Industry Median: 1.51
vs HKSE:02219: 1.14
During the past 8 years, Chaoju Eye Care Holdings's highest 3-Year average Revenue per Share Growth Rate was 23.20% per year. The lowest was 3.50% per year. And the median was 11.30% per year.
Chaoju Eye Care Holdings (HKSE:02219) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Chaoju Eye Care Holdings's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Chaoju Eye Care Holdings PS Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Chaoju Eye Care Holdings's PS Ratio distribution charts can be found below:
* The bar in red indicates where Chaoju Eye Care Holdings's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Chaoju Eye Care Holdings's Share Price of today is HK$2.54.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Chaoju Eye Care Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 was HK$2.23.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Chaoju Eye Care Holdings (HKSE:02219) has a PS Ratio of 1.14 as of Sep. 09, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Chaoju Eye Care Holdings and its competitors. This is 35% below median its historical median of 1.76. Over the past decade, Chaoju Eye Care Holdings' PS Ratio has ranged from 1.08 to 10.86. According to the industry distribution chart, Chaoju Eye Care Holdings ranks #269 out of 659 companies in the Healthcare Providers & Services industry, placing it in the top 40.8%.
Is Chaoju Eye Care Holdings' PS Ratio too high?
Chaoju Eye Care Holdings' current PS Ratio of 1.14 is 35% below median its 10-year median of 1.76. Over the past 10 years, this metric has ranged from a low of 1.08 to a high of 10.86. The Healthcare Providers & Services industry median PS Ratio is 1.51. Chaoju Eye Care Holdings' value of 1.14 is 24.5% below this industry median. Based on the distribution chart, Chaoju Eye Care Holdings ranks #269 out of 659 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Chaoju Eye Care Holdings has a GF Score™ of 93/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Chaoju Eye Care Holdings' PS Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Chaoju Eye Care Holdings ranks #269 out of 659 companies for PS Ratio. This puts Chaoju Eye Care Holdings in the upper half of its industry. The industry median PS Ratio is 1.51. Chaoju Eye Care Holdings' value of 1.14 is 24.5% below this benchmark. Historically, Chaoju Eye Care Holdings' own PS Ratio has ranged from 1.08 to 10.86 over the past decade. While the company's 10-year median is 1.76 vs. the industry median of 1.51, Chaoju Eye Care Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Healthcare Providers & Services company?
The median PS Ratio among Healthcare Providers & Services companies is 1.51, based on 659 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Chaoju Eye Care Holdings's current PS Ratio of 1.14 is 24.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Chaoju Eye Care Holdings and its competitors. For the Healthcare Providers & Services industry, the median PS Ratio is 1.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Chaoju Eye Care Holdings's current PS Ratio is 1.14, which is 35% below median its own 10-year median of 1.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chaoju Eye Care Holdings stock overvalued right now?
Based on GuruFocus' analysis, Chaoju Eye Care Holdings (HKSE:02219) is currently considered Modestly Undervalued. The stock's GF Value™ is HK$3.16, compared to a current price of HK$2.54 — trading 19.6% below its estimated fair value. The current PS Ratio is 1.14, which is 35% below median its 10-year median of 1.76 and 24.5% below the Healthcare Providers & Services industry median of 1.51. Chaoju Eye Care Holdings' overall GF Score™ is 93/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Chaoju Eye Care Holdings (HKSE:02219), the current PS Ratio is 1.14 as of Sep. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Chaoju Eye Care Holdings (HKSE:02219) Overvalued in 2026?
Based on GuruFocus' analysis, Chaoju Eye Care Holdings stock appears to be undervalued.
The current stock price of HK$2.54 is trading 19.6% below its estimated GF Value™ of HK$3.16.
GuruFocus considers Chaoju Eye Care Holdings to be Modestly Undervalued.
Key valuation signals for HKSE:02219:
PS Ratio: 1.14 (35% below median its 10-year median of 1.76)
GF Value™: HK$3.16 vs. price of HK$2.54 (19.6% below fair value)
Industry Position: 24.5% below the Healthcare Providers & Services median (#269 of 659)
No single metric tells the full story. See the HKSE:02219 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Chaoju Eye Care Holdings Ltd is an ophthalmic medical service group in North China engaged in the provision of in-patient services, out-patient services, and sales of optical products. The company generates revenue from consumer ophthalmic services and basic ophthalmic services. The consumer ophthalmic services include treatments and prevention of various types of ophthalmic disorders, including refractive correction, myopia control, and the provision of optical products and services. The basic ophthalmic services include treatments of a wide range of common eye diseases, including cataract, glaucoma, squint, ocular fundus diseases, ocular surface diseases, orbital diseases, and pediatric eye diseases.
93GF Score
Get the complete analysis for HKSE:02219
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02219 has been successfully added to your 
